These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 29303221)
1. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses. Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221 [TBL] [Abstract][Full Text] [Related]
2. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses. Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001 [TBL] [Abstract][Full Text] [Related]
3. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women. Hiett AK; Sonek JD; Guy M; Reid TJ Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862 [TBL] [Abstract][Full Text] [Related]
4. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital. Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting. Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616 [TBL] [Abstract][Full Text] [Related]
7. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. Meys EM; Kaijser J; Kruitwagen RF; Slangen BF; Van Calster B; Aertgeerts B; Verbakel JY; Timmerman D; Van Gorp T Eur J Cancer; 2016 May; 58():17-29. PubMed ID: 26922169 [TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203 [TBL] [Abstract][Full Text] [Related]
9. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study. Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149 [TBL] [Abstract][Full Text] [Related]
10. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Kaijser J; Bourne T; Valentin L; Sayasneh A; Van Holsbeke C; Vergote I; Testa AC; Franchi D; Van Calster B; Timmerman D Ultrasound Obstet Gynecol; 2013 Jan; 41(1):9-20. PubMed ID: 23065859 [TBL] [Abstract][Full Text] [Related]
11. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests. Daemen A; Valentin L; Fruscio R; Van Holsbeke C; Melis GB; Guerriero S; Czekierdowski A; Jurkovic D; Ombelet W; Rossi A; Vergote I; Bourne T; De Moor B; Timmerman D Ultrasound Obstet Gynecol; 2011 Jan; 37(1):100-6. PubMed ID: 20814878 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses. Yang Y; Ju H; Huang Y Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798 [TBL] [Abstract][Full Text] [Related]
13. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods. Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses. Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220 [TBL] [Abstract][Full Text] [Related]
15. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes. Sladkevicius P; Valentin L Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506 [TBL] [Abstract][Full Text] [Related]
16. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses. Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166 [TBL] [Abstract][Full Text] [Related]
17. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk. Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585 [TBL] [Abstract][Full Text] [Related]
18. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer. Poonyakanok V; Tanmahasamut P; Jaishuen A J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122 [TBL] [Abstract][Full Text] [Related]
19. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772 [TBL] [Abstract][Full Text] [Related]
20. Multicentre external validation of IOTA prediction models and RMI by operators with varied training. Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]